RE:RE:RE:RE:RE:RE:RE:RE:Stop Talking and Start DoingAs we have seen so far with this story, nothing solid enough to promote. Recall how we were all disappointed with not having a deal for a functional drink? You would not want to see this stock promoted 2 years ago based on this, or even the NCC deal by the end of 2020 that did not materialize.
So perhaps until a deal is inked or very close to it,or when they need to do an equity financing that is when I would I expect them to truly promote the stock . Perhaps the webcasts are all primers for the investor base.
Minty_33 wrote: "Hopefully if an equity raise is needed they would get their story out there"
That's what I've been eluding to for quite some time. In order for the story to get out though, there needs to be a communication plan. It's very clear that Gilles doesn't have one. Does any shareholder want to have a money raise at these low prices? I don't think so. It's obvious that in order to complete the plant in Germany, more funds will be required. How is Gilles going to finance this seemingly major undertaking? We've heard in the past about licensing deals, cash upfront, royalties and milestone payments blah blah....and that probably wouldn't be sufficient to put the shovel in the ground anyway. As previously posted, Gilles lackadaisical M/O is hurting the future prospects of this company. Ceapro has a current market cap of 51 Million with sales North of 15 Million a year and profitable. Draganfly (DFLY) which I have done well on on has a market cap of 160 Million with 4.3 Million and losing money (albeit the company is growing) . Why is it trading at a premium so to speak? Because they know how to tell the story! And people have confidence in the CEO to execute deals. When it comes to growth, I hope the company doesn't settle for that Mickey Mouse deal as a result of the reticence that Gilles lives by.
The story must get out now so when the money is needed the company will will be able to acquire more as a result of the valuation.